OSF Ventures and Wanxiang Healthcare Investments are among the backers of a $45m series D round in heart monitoring platform Endotronix.
US-based patient management technology developer Endotronix has closed a $45m series D round backed by healthcare provider OSF Healthcare and auto components producer Wanxiang.
LSP led the round through its LSP Health Economics Fund 2 and was joined by an additional, unnamed corporate investor as well Aperture Venture Partners, BioVentures Investors, Lumira Ventures, Seroba Life Sciences and SV Health Investors.
OSF Healthcare took part through its corporate venturing unit OSF Ventures, while Wanxiang participated through its Wanxiang Healthcare Investments division.
…
